PCM
AMPE

Palisade Capital Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Palisade Capital Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-117
Closed -$83K – 581
2015
Q2 		$83K Buy
+117
New +$125K ﹤0.01% 522

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CK
Carnick & Kubik Colorado Springs, Colorado $334M AUM 1.52% 1-Year Est. Return
TMC
Trellus Management Company Delray Beach, Florida $72.8M AUM 4.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Palisade Capital Management's AMPE Position: Q3 2015 in Review

Palisade Capital Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2015, closing a stake of 117 shares — an estimated $83K sold.

Palisade Capital Management first reported a position in AMPE in Q2 2015 and held it in 1 quarter. The position peaked at $83K in Q2 2015. 51 funds tracked by Wall St. Rank hold AMPE as of Q3 2015.

  • Palisade Capital Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2015 after selling out during the quarter.
  • Palisade Capital Management sold 117 Ampio Pharmaceuticals Inc. shares in Q3 2015, an estimated $83K.
  • Palisade Capital Management first reported a position in Ampio Pharmaceuticals Inc. in Q2 2015 and held it in 1 quarter.
  • Palisade Capital Management's Ampio Pharmaceuticals Inc. position peaked at $83K in Q2 2015.
  • 51 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2015.

Based on Palisade Capital Management's 13F filing for Q3 2015, filed 29 Oct 2015.